NCT01772771View on ClinicalTrials.gov

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

RecruitingOBSERVATIONAL
Enrollment

12,000

Participants

Timeline

Start Date

March 1, 2012

Primary Completion Date

March 1, 2032

Study Completion Date

March 1, 2033

Conditions
GliomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMelanomaSarcoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood, saliva/buccal swab samples

OTHER

Genetic Testing

Correlative studies

OTHER

Medical Chart Review

Review of medical records

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01772771 - Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program | Biotech Hunter | Biotech Hunter